Get Zepbound Online: LillyDirect vs Telehealth

Yes. You can get Zepbound online: a telehealth visit for the prescription, then a mail-order pharmacy. Self-pay starts at $299 a month (LillyDirect: LillyDirect vial or KwikPen 2.5 mg). WeightWatchers Med+ charges $373 a month all in.

Lowest self-pay: $299 a month
Telehealth from, all in: $373 a month
Prescription: RequiredFDA label (DailyMed)
Shortage: Resolved

Zepbound in brief

How long it remains in your body

With a half-life of 5 to 6 days, half the drug is gone after 5.5 d. About 3% remains after five half-lives (27.5 d).

Main trial's reported weight loss

Placebo produced 3.1% weight loss in SURMOUNT-1 over 72 weeks, compared with 20.9% in the treatment group.

What prices look like over time

The maker's price page lists monthly prices in US dollars for both list-price and self-pay offers.

Sources: FDA label (DailyMed), Eli Lilly 1 2, cnbc.com.

Every legitimate way to get Zepbound, ranked

Ways to get it, cheapest first
Route	Who it is for	What you pay
Your doctor, with insurance and the savings card	Commercial insurance that covers it	From $25 for a fill of up to 3 months
LillyDirect: LillyDirect vial or KwikPen 2.5 mg	Anyone with a prescription, no insurance needed	$299 a month
TrumpRx listing (vial, starting)	Self-pay only	$299 a month
Walmart Pharmacy: LillyDirect self-pay (lowest dose)	Cash at the pharmacy counter	$299 a month
Telehealth: WeightWatchers Med+, Zepbound (self-pay)	Online visit, medicine shipped	$373 a month all in

Prices checked November 2026. Each price links back to the page it came from.

Sources: pricinginfo.lilly.com, zepbound.lilly.com, Eli Lilly, TrumpRx.

Who qualifies

Every GLP-1 sold in the US requires a prescription. For a use the label approves, a prescriber writes it:

For long-term weight loss and maintenance with diet and activity, it is for adults with obesity or those overweight with a weight-related condition.
For adults with obesity, it treats moderate to severe obstructive sleep apnea.

Needed: FDA label (DailyMed)

Comparing telehealth options

Telehealth programs for Zepbound
Program	Medicine option	Medicine price	Membership	All in
WeightWatchers Med+	Zepbound (self-pay)	$299 a month	$74 a month	$373 a month
Ro	Zepbound KwikPen, starting dose	$299 a month	$149 a month	$448 a month
Hims & Hers	Zepbound	$1,899 a month	$149 a month after first month	$2,048 a month

Each price is taken from that program's own pricing page. None of them brings us any income.

Sources: weightwatchers.com, ro.co, hims.com.

Shortage status

Tirzepatide: Shortage resolved. The FDA confirmed this on December 19, 2024.

First added to the FDA shortage list: December 15, 2022
Shortage resolved: December 19, 2024
February 18, 2025: Compounding copies had to stop at state pharmacies
March 19, 2025: Outsourcing facilities were required to stop

Source: FDA.

Scam signals

No prescription needed: sellers that skip the prescription are not licensed US pharmacies.
The brand priced well under the manufacturer's own: the manufacturer gives $299 a month as its lowest self-pay price.
Even when compounded drugs are sold as the brand, they lack FDA approval, so they are not Ozempic, Wegovy, Mounjaro or Zepbound.
Calling a drug the same as the brand: 30 warning letters went out from the FDA to telehealth companies over misleading claims.
The FDA has on file more than 730 adverse event reports involving compounded tirzepatide.
One program quoted a monthly price that left out the drug, and the FTC acted against it.

Sources: pricinginfo.lilly.com, zepbound.lilly.com, Eli Lilly, TrumpRx.

Find it in the state where you live

Hims & Hers: Coverage does not include every one of the 50 states
Noom Med: Coverage does not include every one of the 50 states
Delivery is available across all 50 states, plus DC, Puerto Rico, through NovoCare Pharmacy

The route changes most under Medicaid rules. for weight loss, GLP-1s are covered by 10 state Medicaid programs right now. Select your state to review its drug list and prior authorization rules:

Sources: hims.com, noom.com, NovoCare.